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The noncatalytic src homology region 2 segment of abl tyrosine
kinase binds to tyrosine-phosphorylated cellular proteins with
high affinity
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ABSTRACT Several proteins implicated in the regulation
of cell proliferation contain a common noncatalytic domain, src
homology region 2 (SH2). We have used the bacterially ex-
pressed SH2 domain of abl protein-tyrosine kinase to evaluate
the ability of this domain to bind to cellular proteins. abI SH2
specifically bound to a number of tyrosine-phosphorylated
proteins from cells transformed by tyrosine kinase oncogenes in
a filter-binding assay and to a subset of those proteins in
solution. The SH2 probe bound almost exclusively to tyrosine-
phosphorylated proteins, and binding was eliminated by de-
phosphorylation of cell proteins. Free phosphotyrosine could
partially disrupt SH2 binding, suggesting that phosphotyrosine
is directly involved in the binding interaction. These results
demonstrate that an SH2 domain is sufficient to confer direct,
high-affinity phosphotyrosine-dependant binding to proteins
and suggest a general role for SH2 domains in cellular signaling
pathways.
The abl gene product is a member of the nonreceptor class of
protein-tyrosine kinases and can induce malignant transfor-
mation when altered during retroviral transduction or chro-
mosomal translocation (1-4). The amino terminus of the abl
kinase contains an 80-amino acid domain, termed src homol-
ogy region 2 (SH2) (5, 6) that is found in all known nonre-
ceptor tyrosine kinases, a phosphatidylinositol-specific phos-
pholipase C (PLC-'y), the ras GTPase activator protein
(GAP), and the crk oncogene product (7-12); each of these
proteins has been implicated in growth-control pathways.
SH2 domains are not required for catalytic activity of en-
zymes in which they are found (12-16), but mutations in this
domain can have profound effects on biological activity (6,
17-20). PLC-y, GAP, and the src family of tyrosine kinases
have recently been shown to bind to growth-factor receptors
after ligand binding (21-26), and the crk protein binds phos-
photyrosine-containing proteins and protein kinase activities
(27, 28), raising the possibility that SH2 domains might
mediate protein-protein interactions important to growth
control. We therefore investigated whether the isolated SH2
domain of abi could specifically bind to cellular proteins in
vitro.
MATERIALS AND METHODS
Generation of Bacterially Expressed SH2 Probe. A BamHI
12-mer linker was inserted at the HincII site at amino acid 144
of type IV c-abl, and the 0.3-kilobase (kb) BamHI-HinPI
fragment was subcloned into pGEX-2T (29) cut with BamHI
and Sma I. Bacteria were grown and proteins purified es-
sentially as described (29).
Bacterial proteins were coupled at room temperature for 4
hr with biotinamidocaproate N-hydroxysuccinimide ester
(Sigma) in 100 mM sodium borate, pH 8.8, at a bacterial
peptide concentration of 3 mg/ml and biotin ester at 50
Ag/mg of peptide. Biotinylated peptide was purified by gel
filtration.
Binding Assays. Tissue-culture cells were lysed on ice in
Triton extraction buffer [10 mM Tris, pH 7.4/150mM NaCl/5
mM EDTA/10% (vol/vol) glycerol/1% Triton X-100/1 mM
phenylmethylsulfonyl fluoride/aprotinin at 0.25 trypsin in-
hibitor unit per ml/1 mM sodium orthovanadate, unless
specified]. Equal amounts of protein were boiled in Laemmli
sample buffer, separated on 8.5% acrylamide gels (except
Fig. 3B, which is a 7-10%6 gradient gel), and transferred to
nitrocellulose in 10mM 3-(cyclohexylamino)-1-propanesulfo-
nic acid (CAPS), pH 11/20% (vol/vol) methanol. Filters were
blocked in 10 mM Tris, pH 8.0/0.9% NaCl/0.05% Tween 20
(TBST buffer) plus 0.2% gelatin or 1% ovalbumin (Sigma
fraction V). Biotinylated probes were added in the same
buffer at 1-2 gg/ml, incubated at room temperature 1-2 hr,
and washed extensively in TBST. Filters were incubated with
avidin-conjugated alkaline phosphatase at 2 ,g/ml in TBST,
washed, and developed with Nitro blue tetrazolium and
X-phosphate (Promega Biotec).
For immunoblotting with monoclonal anti-ptyr antibody,
filters were treated as above, except affinity-purified PY20
immunoglobulin was used at 2 Ag/ml instead of biotinylated
peptides, and bound antibody was detected with goat anti-
mouse-conjugated alkaline phosphatase (Promega Biotec).
SH2 and the glutathione S-transferase fusion partner lack-
ing abI sequences (GEX) peptides were coupled to Affi-Gel
10 beads (Bio-Rad) at 2 mg of peptide per ml of beads
following the manufacturer's recommendations. Cell pro-
teins were incubated in Triton extraction buffer with coupled
beads for 1 hr at 40C (-50 1Lg of cell protein per ul of beads
or equivalent fraction ofpurified phosphotyrosine-containing
proteins) and then washed with Triton extraction buffer and
the same buffer containing 10 mM NaCl before SDS/PAGE.
RESULTS
To generate a probe to identify possible SH2-binding pro-
teins, we expressed a 100-amino acid fragment that contains
the entire SH2 domain of c-abl in Escherichia coli. The abI
sequences were fused downstream ofthe glutathione S-trans-
ferase gene in the pGEX expression vector, allowing rapid
purification of the fusion protein on glutathione agarose (29).
The purified fusion protein (termed SH2) and the GEX
Abbreviations: SH2, src homology region 2; PLC, phospholipase C;
GAP, ras GTPase activator protein; GEX, glutathione S-transferase
fusion partner lacking abl sequences.
627
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 88 (1991)
Probe SH2 SH2 SH2 GEX
Block GEX SH2
1 2 3 4 5 6 7 8
FIG. 1. abl SH2 peptide specifically binds to proteins in abl-
transformed cells. Lysates were prepared from NIH 3T3 cells (lanes
2, 4, 6, 8) or 3T3 cells transformed by the activated c-abl mutant AXB
(lanes 1, 3, 5, 7). Equal amounts of protein were separated by
SDS/PAGE and transferred to nitrocelluose filters. Identical filters
yvere incubated with biotinylated SH2 probe (lanes 1 and 2), GEX
probe (lanes 7 and 8), or SH? probe plus 100-fold excess of unbiot-
inylated GEX (lanes 3 and 4) or SH2 (lanes 5 and 6) peptide, and
bound proteins were detected with avidin-conjugated alkaline phos-
phatase. Arrows indicate prominent specific SH2-binding proteins.
Bars indicate the positions ofmolecular mass standards: 200, 106, 71,
44, and 28 kDa.
protein were biotinylated, permitting detection with avidin-
conjugated alkaline phosphatase.
We developed a filter-binding assay in which lysates of
tissue-culture cells were separated by SDS/PAGE, trans-
ferred to nitrocellulose membranes, and probed with the
biotinylated bacterial proteins. A number of proteins were
labeled by the SH2 probe but not by the GEX probe (Fig. 1,
lanes 1 and 7). Binding was eliminated by competition with
100-fold excess ofunlabeled SH2 peptide but not by the GEX
peptide (lanes 3 and 5), demonstrating that binding was not an
artifact of biotinylation. The majority of the labeled proteins
were observed only in lysates from cells transformed by an
activated abl tyrosine kinase (AXB; ref. 30) and were not
observed in lysates of parental 3T3 cells (compare lanes 1 and
2). The precise number of bands specifically labeled by the
SH2 probe varied slightly in different experiments, but prom-
inent bands of -210, 85, 65-70, 38, and 34 kDa were
consistently seen.
Because specific labeling by SH2 was seen with abl-
transformed but not normal cell lysates, we examined
whether tyrosine phosphorylation was involved in recogni-
tion by SH2. We prepared identical lysates from parallel
dishes of cells with the exception that the potent tyrosine
phosphatase inhibitor sodium orthovanadate (31, 32) was
included in one set. Lysates were incubated on ice for several
hours to allow dephosphorylation of tyrosine residues by
endogenous phosphatases in the lysates lacking vanadate.
When the paired lysates were assayed for binding to SH2,
much less binding to proteins prepared without vanadate was
observed (Fig. 2A, lanes S and 6), suggesting that SH2 binding
depended on tyrosine phosphorylation. Protease inhibitors
were included in both lysates, and no differences in nonspe-
cific background bands were seen, so differences in SH2
binding were probably not due to proteolysis. An identical
immunoblot probed with a monoclonal antibody that specif-
ically recognizes phosphotyrosine residues (anti-ptyr) (33,
34) demonstrated that dephosphorylation had occurred; fur-
thermore, anti-ptyr labeled major proteins with the same
apparent molecular masses as those labeled by SH2, again
suggesting that those proteins that bound SH2 were tyrosine-
phosphorylated (Fig. 2A, lanes 1 and 2).
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FIG. 2. The SH2 peptide binds to tyrosine-phosphorylated proteins. (A) AXB or 3T3 lysates were prepared in Triton X-100 lysis buffer with or
without 1 mM sodium orthovanadate (VO4) as marked and incubated on ice for 2 hr. After SDS/PAGE and transfer to nitrocellulose, identical filters
were immunoblotted with anti-ptyr (Anti-Ptyr) (33) (lanes 1-4) or probed with biotinylated SH2 (lanes 5-8) or GEX (lanes 9-12) peptides as in Fig.
1. Arrows indicate prominent phosphotyrosine-containing or SH2-binding proteins. (B) AXB lysates were fractionated by affinity chromatography
on anti-ptyr beads into flow-through (FT) and bound fractions (33, 34). Total (lanes 1 and 4), flow-through (lanes 2 and 5), and bound (lanes 3 and
6) fractions were separated by SDS/PAGE and transferred to nitrocellulose, and identical filters were probed with biotinylated SH2 (lanes 1-3) or
GEX (lanes 4-6) as in Fig. 1. Protein in bound fractions represents 3.5 times the fraction of total lysate used in total and flow-through lanes.
0
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To demonstrate more directly that the SH2 probe recog-
nized proteins that contained phosphotyrosine residues, we
prepared phosphotyrosine-containing proteins from AXB-
transformed cells by incubating lysates with anti-ptyr cou-
pled to beads and eluting bound proteins with free phospho-
tyrosine (33, 34). The SH2 probe bound few, if any, proteins
in the anti-ptyr flow-through fraction (Fig. 2B, lane 2) but
bound to many proteins in the anti-ptyr-bound fraction (lane
3). In contrast, most total protein was in the flow-through
fraction. These results strongly suggest that SH2 binds ex-
clusively to tyrosine-phosphorylated proteins.
We have also examined whether the abl SH2 domain could
recognize tyrosine-phosphorylated proteins from cells ex-
pressing tyrosine kinase oncogenes other than abl. The abl
SH2 probe bound specifically to several proteins from lysates
of 3T3 cells transformed by the v-src and v-fps oncogenes.
The bands labeled corresponded to major phosphotyrosine-
containing proteins identified by anti-ptyr immunoblotting,
and binding was abrogated by incubation of lysates in the
absence of vanadate or by blocking binding reactions with
excess unbiotinylated SH2 peptide (data not shown). The
SH2 probe also specifically bound to tyrosine-phosphory-
lated proteins from an abl-transformed murine pre-B cell line
(data not shown).
Cell proteins in the filter-binding assay are presumably
partially or completely denatured and are separated from
other proteins to which they might be bound in intact cells.
To examine the ability ofthe abl SH2 peptide to bind to native
proteins, SH2 and GEX peptides were covalently coupled to
beads and incubated with Triton X-100 lysates of AXB-
transformed cells; bound phosphotyrosine-containing pro-
teins were detected by immunoblotting with anti-ptyr. In
contrast to the approximate equivalence between the SH2-
bound and phosphotyrosine-containing proteins in the filter-
A SH2 B GEX SH2
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binding assay, only a small subset of the phosphotyrosine-
containing proteins bound to the SH2 beads (Fig. 3A, lane 3).
A 65- to 68-kDa doublet (and occasionally a 34-kDa species)
were the only proteins quantitatively retained by the beads.
Similarly, when purified phosphotyrosine-containing pro-
teins (prepared by immunoaffinity chromatography as in Fig.
2B) were incubated with SH2 beads, the 65- to 68-kDa
doublet was the major species bound (Fig. 3B, lane 4). Thus,
in solution, the abI SH2 domain has a much higher affinity for
the 65- to 68-kDa species than for other tyrosine-phos-
phorylated proteins. The apparent difference between the
binding specificities observed in solution and in the filter-
binding assay implies an inaccessibility of SH2-binding sites
in solution; for example, these sites might already be bound
to endogenous SH2-containing proteins or the proteins might
be folded so as to make access difficult. However, when
32P-labeled AXB lysates were bound to SH2 beads, promi-
nent higher molecular mass SH2-binding phosphoproteins
were observed, including 85- and 210-kDa species (data not
shown), indicating that SH2 binding in solution is not entirely
restricted to the 65- to 68-kDa species.
To examine whether free phosphotyrosine could compete
with phosphotyrosine-containing proteins for binding to
SH2, SH2 beads containing bound phosphotyrosine-
containing proteins from AXB-transformed 3T3 lysates were
incubated with 20 mM phosphotyrosine. These conditions
are sufficient to liberate phosphotyrosine-containing proteins
bound to anti-ptyr antibodies (refs. 33 and 34 and data not
shown). A fraction of the phosphotyrosine-containing pro-
teins was eluted from the SH2 beads by phosphotyrosine but
not by phosphoserine at the same concentration (Fig. 4;
compare lanes 3 and 4). We have found that it is very difficult
to release proteins bound to SH2 beads under a variety of
conditions; for example, treatment with 100 mM glycine, pH
2.5, released only a small fraction of bound proteins (data not
shown). We therefore feel that the amount of bound protein
released by phosphotyrosine is significant. The inefficient yet
specific elution with free phosphotyrosine suggests that phos-
photyrosine is directly involved in SH2 binding but does not
constitute the entire binding site. Consistent with this, we
have also found that 1 mM phosphotyrosine decreased but
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FIG. 3. SH2 peptide coupled to beads binds a subset of tyrosine-
phosphorylated proteins (A) Lysates were prepared from AXB cells
and incubated with beads covalently coupled to abl SH2 peptide.
Total (lane 1), flow-through (FT) (lane 2), and bound (lane 3) fractions
were separated by SDS/PAGE, transferred to nitrocellulose, and
immunoblotted with anti-ptyr. Arrow denotes major SH2-binding
species. (B) Phosphotyrosine-containing proteins were prepared by
affinity chromatography on anti-ptyr, eluted, and incubated with
beads coupled to GEX (lanes 1 and 2) or SH2 (lanes 3 and 4) peptide
as marked. Proteins in the flow-through (FIT) (lanes 1 and 3) and
bound (lanes 2 and 4) fractions were immunoblotted with anti-ptyr.
Arrow indicates major SH2-binding species (65- to 68-kDa doublet).
FIG. 4. Phosphotyrosine partially disrupts SH2 binding. AXB
lysates were incubated with GEX beads or SH2 beads as in Fig.3.
After binding to cell proteins, SH2 beads were incubated in Triton
X-100 lysis buffer containing 20 mM phosphoserine, the eluate was
then collected, and the beads were further incubated in 20 mM
phosphotyrosine. Proteins in each fraction were boiled in SDS
sample buffer and analyzed by immunoblotting with anti-ptyr.
Lanes: 1, total lysate; 2, proteins bound to GEX beads; 3, proteins
eluted from SH2 beads with phosphoserine; 4, proteins subsequently
eluted from SH2 beads with phosphotyrosine; 5, proteins remaining
bound to SH2 beads after elution with phosphoserine and phospho-
tyrosine. Arrow indicates major SH2-binding species.
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did not eliminate SH2 binding in the filter-binding assay,
whereas phosphoserine had no effect (data not shown).
DISCUSSION
We have shown that the SH2 domain of the abl tyrosine
kinase can tightly associate with tyrosine-phosphorylated
proteins both on nitrocellulose filters and in solution. The
filter-binding assay demonstrates that SH2 binding to phos-
photyrosine-containing proteins is direct and not mediated by
unidentified associated proteins because cell lysates were
separated by SDS/PAGE before transfer to filters. We have
not analyzed the kinetics of SH2 binding in the filter assay,
but the affinity must be very high because the concentration
of SH2 probe in the binding reaction was <1O-0 M and the
filters were washed extensively after binding. Although the
abl SH2 binds to virtually all phosphotyrosine-containing
proteins in the filter assay, only a subset of these bind in
solution. This result suggests both that SH2 domains have the
potential to bind to many proteins and that this potential
could be modulated in vivo by such factors as accessibility of
binding sites and local concentration.
We propose that tyrosine phosphorylation is required for
high-affinity binding of proteins to the abl SH2 domain based
on the following evidence. All bands labeled by the SH2
probe comigrate with major phosphotyrosine-containing pro-
teins detected by anti-ptyr; dephosphorylation of these pro-
teins abrogates SH2 binding. Furthermore, in AXB lysates,
virtually all SH2-binding proteins are also bound by anti-ptyr
(Fig. 2). We have performed phosphoamino acid analysis on
two proteins that bind to SH2 beads, and in both cases at least
50% of phosphate was on tyrosine residues (data not shown).
We have shown that phosphotyrosine, and not phospho-
serine, can partially elute phosphotyrosine-containing pro-
teins from SH2 beads (Fig. 4) and can partially block SH2
binding in the filter assay (data not shown). In sum, these data
suggest that SH2 directly recognizes phosphotyrosine in cell
proteins, as opposed to a phosphorylation-induced confor-
mational change.
The demonstration that an SH2 domain can directly bind to
tyrosine-phosphorylated proteins has general implications
for the mechanisms of cellular signal transduction. SH2
domains have been found to date only in proteins implicated
in the modulation ofgrowth control: the nonreceptor tyrosine
kinases, PLC-y, GAP, and the crk oncogene product (6-12).
PLC-y, GAP, and the src family of tyrosine kinases have
been shown to bind to activated (tyrosine-phosphorylated)
growth-factor receptors (21-26), and crk protein binds to a
number of phosphotyrosine-containing proteins (27, 28). In
many of these cases, SH2 domains have recently been shown
to be sufficient for binding (refs. 35 and 36; M. Matsuda,
B.J.M., and H. Hanafusa, unpublished work). It is likely that
a general function of SH2 domains in proteins is to mediate
the phosphotyrosine-dependent assembly of multiprotein
complexes involved in cellular responses to liganded recep-
tors. A tyrosine-phosphorylation event, such as growth-
factor receptor autophosphorylation, could trigger the colo-
calization of a whole class of SH2-binding proteins to a
specific cellular site. The fact that both PLC-y and GAP have
two SH2 domains and are themselves tyrosine phosphory-
lated upon growth-factor stimulation (37-40) suggests that
these proteins could form multimeric networks based on
SH2-phosphotyrosine interaction.
There is no evidence yet that c-abl protein or its trans-
forming variants can complex with growth-factor receptors,
so the specific function of the abl SH2 domain is unclear.
Because most overexpressed c-abl protein is found in the
nucleus (41), unlike v-abl or other SH2-containing proteins
that are cytosolic or membrane-associated, in normal cells
the c-abl SH2 could participate in a specific set of phospho-
tyrosine-mediated interactions. The ablSH2 domain appears
to bind to virtually all phosphotyrosine-containing proteins in
the filter assay; we have not yet attempted to identify any of
these SH2-binding proteins. The major protein that binds to
the abl SH2 domain in solution, a 65- to 68-kDa doublet, is
reminiscent of proteins of approximately the same molecular
mass that have been reported to bind to GAP and crk (27, 28,
35, 40).
Because we have shown that the abl SH2 domain has a
much higher affinity for tyrosine-phosphorylated proteins
than for unphosphorylated potential substrates, the presence
of SH2 domains in the nonreceptor tyrosine kinases is
intriguing. This result suggests that the nonreceptor kinases
would bind tightly to their reaction products, making them
poorly suited to rapidly phosphorylate a number of sub-
strates. It is possible, however, that the SH2 domains of the
tyrosine kinases are actually sequestered in inter- or intra-
molecular interactions that regulate activity of the catalytic
domain, especially given that all of the nonreceptor tyrosine
kinases have multiple tyrosine phosphorylation sites (42-44).
In vitro studies with purified nonreceptor tyrosine kinases,
their SH2 domains, and natural substrates will be required to
assess the significance of SH2-phosphotyrosine interactions
in the regulation of kinase activity.
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